ID30030A - GIVING AS WELL AS ACQUISITOR AND MMP FOR TREATMENT OF ATEROSCLEROSIS Wounds - Google Patents

GIVING AS WELL AS ACQUISITOR AND MMP FOR TREATMENT OF ATEROSCLEROSIS Wounds

Info

Publication number
ID30030A
ID30030A IDW20010333A ID20010333A ID30030A ID 30030 A ID30030 A ID 30030A ID W20010333 A IDW20010333 A ID W20010333A ID 20010333 A ID20010333 A ID 20010333A ID 30030 A ID30030 A ID 30030A
Authority
ID
Indonesia
Prior art keywords
aterosclerosis
acquisitor
mmp
wounds
giving
Prior art date
Application number
IDW20010333A
Other languages
Indonesian (id)
Inventor
Thomas Michael Andrew Bocan
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ID30030A publication Critical patent/ID30030A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IDW20010333A 1998-07-21 1999-06-18 GIVING AS WELL AS ACQUISITOR AND MMP FOR TREATMENT OF ATEROSCLEROSIS Wounds ID30030A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9363998P 1998-07-21 1998-07-21

Publications (1)

Publication Number Publication Date
ID30030A true ID30030A (en) 2001-11-01

Family

ID=22239992

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010333A ID30030A (en) 1998-07-21 1999-06-18 GIVING AS WELL AS ACQUISITOR AND MMP FOR TREATMENT OF ATEROSCLEROSIS Wounds

Country Status (25)

Country Link
EP (1) EP1098662A2 (en)
JP (1) JP2002521328A (en)
KR (1) KR20010083134A (en)
CN (1) CN1310629A (en)
AP (1) AP2001002035A0 (en)
AU (1) AU4701799A (en)
BG (1) BG105162A (en)
BR (1) BR9912296A (en)
CA (1) CA2335062A1 (en)
CZ (1) CZ2001126A3 (en)
EA (1) EA200100153A1 (en)
EE (1) EE200100046A (en)
HR (1) HRP20010055A2 (en)
HU (1) HUP0102880A3 (en)
ID (1) ID30030A (en)
IL (1) IL140982A0 (en)
IS (1) IS5809A (en)
NO (1) NO20010291D0 (en)
OA (1) OA11584A (en)
PL (1) PL346011A1 (en)
SK (1) SK502001A3 (en)
TR (1) TR200100205T2 (en)
WO (1) WO2000004892A2 (en)
YU (1) YU3501A (en)
ZA (1) ZA200100294B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020050257A (en) * 1999-11-05 2002-06-26 로즈 암스트롱, 크리스틴 에이. 트러트웨인 Prevention of Plaque Rupture by ACAT Inhibitors
DOP2000000107A (en) 1999-12-01 2002-09-16 Agouron Pharmaceutical Inc COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND LENGTH OF NEURONS
AU2268401A (en) * 1999-12-17 2001-06-25 Versicor Inc Novel succinate compounds, compositions and methods of use and preparation
EP1314423A4 (en) * 2000-09-01 2004-05-19 Sankyo Co Medicinal compositions
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
JP4606027B2 (en) * 2002-04-03 2011-01-05 トポターゲット ユーケー リミテッド Carbamate compounds having piperazine bonds as HDAC inhibitors
JP4617449B2 (en) * 2002-07-11 2011-01-26 ヴィキュロン ファーマシューティカルズ インコーポレイテッド N-hydroxyamide derivative having antibacterial activity
WO2011092284A1 (en) * 2010-01-29 2011-08-04 Euroscreen S.A. Novel amino acid derivatives and their use as gpr43 receptor modulators
CN104211695B (en) * 2013-06-04 2017-04-12 中国医学科学院医药生物技术研究所 Use of group of carbamyl phenylsulfonyl compounds
US20180000817A1 (en) * 2015-01-15 2018-01-04 Biocant - Associação De Transferência De Tecnologia Treatment of hutchinson-gilford progeria syndrome and diseases related to vascular ageing
CN106831697B (en) * 2017-03-15 2019-11-05 深圳市康道生物有限公司 The effective extract component of river hazel and its application in prevention and treatment atherosclerosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
CN1192140A (en) * 1995-08-04 1998-09-02 沃尼尔·朗伯公司 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels
KR20000011095A (en) * 1996-05-17 2000-02-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 Nonphenyl sulfoneamide as inhibitor of matrix metalloproteinase
WO1998009934A1 (en) * 1996-09-04 1998-03-12 Warner-Lambert Company Matrix metalloproteinase inhibitors and their therapeutic uses

Also Published As

Publication number Publication date
YU3501A (en) 2005-06-10
WO2000004892A3 (en) 2000-05-18
HRP20010055A2 (en) 2002-04-30
HUP0102880A3 (en) 2002-11-28
ZA200100294B (en) 2002-01-10
CZ2001126A3 (en) 2002-01-16
EA200100153A1 (en) 2001-08-27
CN1310629A (en) 2001-08-29
NO20010291L (en) 2001-01-18
AU4701799A (en) 2000-02-14
IS5809A (en) 2001-01-12
WO2000004892A2 (en) 2000-02-03
IL140982A0 (en) 2002-02-10
BR9912296A (en) 2001-04-17
KR20010083134A (en) 2001-08-31
EE200100046A (en) 2002-06-17
JP2002521328A (en) 2002-07-16
CA2335062A1 (en) 2000-02-03
PL346011A1 (en) 2002-01-14
SK502001A3 (en) 2002-06-04
TR200100205T2 (en) 2001-05-21
OA11584A (en) 2004-07-20
AP2001002035A0 (en) 2001-03-31
NO20010291D0 (en) 2001-01-18
HUP0102880A2 (en) 2002-06-29
BG105162A (en) 2001-12-29
EP1098662A2 (en) 2001-05-16

Similar Documents

Publication Publication Date Title
ID28787A (en) SUBSTITUTED 2-PHENILBENZIMIDAZOL, ITS MAKING AND USE OF IT
ID30393A (en) TIENOPIRIMIDINA COMPOUNDS, MAKING AND USE OF IT
ID27859A (en) TAMPON AND THE METHOD OF MAKING IT
ID22957A (en) COMPOUND AND ITS USE
ID21863A (en) COMPOUNDS OF KINOLIN AND KINAZOLIN USED IN THERAPY, SPECIFICALLY IN TREATMENT OF TYPICAL PROSTATIC HEPERPLASIA
ID29434A (en) COMBINATIONS OF HERBISIDE AND SECURITY
CY2006003I2 (en) USE OF DAPTOMYCIN
NO20012984D0 (en) Succinoylamino benzodiazepines as inhibitors of AB protein production
DE69923810D1 (en) Hemostatic agent
ID25469A (en) STORIES OF CHRISTALOGRAPHY AND THE PROCESS OF MAKING AMORF SEFALOSPORINE
ID21332A (en) METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF HYPERURICEMIA
ID23514A (en) MONOLEFINIC C5 MONONITRIL, MANUFACTURE AND USE OF IT
ID30030A (en) GIVING AS WELL AS ACQUISITOR AND MMP FOR TREATMENT OF ATEROSCLEROSIS Wounds
ID20137A (en) PROPANOLAMINA DECREASED, THE PROCESS OF MAKING, PHARMACEUTICAL PROPERTIES THAT CONTAIN THIS COMPOUND, AND ITS USE
DE69934889D1 (en) PREPARATION AND PURIFICATION OF DIBORANESE
NO20001847D0 (en) New use of compounds for anti-itch activity
ID26839A (en) FUNICIDAL MIXES OF TRIS (OXIMETER) AND INSECTICIDE BASICS
ID28025A (en) METHOD OF MAKING AMINONITRIL AND DIAMINA
FR2809000B1 (en) USE OF ERGOTHIONEIN AND / OR ITS DERIVATIVES AS AN ANTI-POLLUTION AGENT
ID26297A (en) PANTS TYPES OF SHORT USE PANTS AND ITS PROCESSING
ID28368A (en) PLANTS OF MICROSATELITE PLANTS AND METHODS OF USE
ID28894A (en) METHODS AND COMPOSITION FOR TREATMENT OF GASTRO-ESOPHAGEAL DISEASES
DE69926485D1 (en) TREATMENT OF PASSENGER GASES
ID28797A (en) TIOREDOXINATION AND PROCESSING OF SEEDS
ID24065A (en) TREATMENT OF DIABETES WITH TIOZOLIDINDINONE AND SULFONILUREA